ABOUT CONOLIDINE

These results, along with a previous report showing that a small-molecule ACKR3 agonist CCX771 exhibits anxiolytic-like behavior in mice,2 guidance the principle of targeting ACKR3 as a novel approach to modulate the opioid system, which could open new therapeutic avenues for opioid-linked Ailments.(3) Apart from when the individual was prescribed